BridgeMD
Tests treatment safety and results for Hypertension (HTN)
Official title An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
ClinicalTrials.gov ID: NCT07543120
What this study is testing
What is QCZ484?
QCZ484 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for hypertension (htn).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Signed informed consent must be obtained prior to participation in the study.
- Successful completion of treatment period on QCZ484 study medication in parent study.
- No significant safety issue that may place participant at safety risk as determined by the Investigator.
You likely can't join if
- Participants meeting any of the following criteria, may it be pre-existing or developed during the parent study, are not eligible for inclusion in...
- Evidence of hepatic disease that would put participant at risk by taking QCZ484 for long term as determined by the Investigator.
- Clinically significant cardiac arrhythmias (e.g., ventricular tachycardia), high-grade atrioventricular (AV) block (e.g., Mobitz type II and...
- Permanent or persistent atrial fibrillation developed during the parent study.
- Clinically significant valvular heart disease developed during the parent study.
- Acute myocardial infarction (AMI) or unstable angina, or any percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)...
The study team makes the final eligibility decision.
Where it's taking place
- Garden Grove, California, United States
- Los Angeles, California, United States
- Miami, Florida, United States
- Miami Lakes, Florida, United States
- Wellington, Florida, United States
- Fayetteville, Georgia, United States
- Ft. Washington, Maryland, United States
- Jefferson City, Missouri, United States
- Monroe, North Carolina, United States
- Suita, Osaka, Japan
- Shinjuku Ku, Tokyo, Japan
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Garden Grove, California, United States; Los Angeles, California, United States; Miami, Florida, United States; Miami Lakes, Florida, United States; Wellington, Florida, United States; Fayetteville, Georgia, United States and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.